#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Renal cell carcinoma Breast angiosarcoma Warm autoimmune haemolytic anaemia Ductal adenocarcinoma of pancreas Anti-myelin-associated glycoprotein antibodies positive Medulloblastoma Activated PI3 kinase delta syndrome Sarcoidosis Pustular psoriasis Hereditary angioedema Chronic lymphocytic leukaemia refractory Autoimmune demyelinating disease Factor IX deficiency White matter lesion More trials…

    Learn about Rare Diseases

    IgA nephropathy Lysosomal storage disorder – Diagnostics X-linked lymphoproliferative syndrome – Life with Disease Rosai-Dorfman syndrome – Diagnostics Alveolar rhabdomyosarcoma – Treatment Medulloblastoma recurrent Crigler-Najjar syndrome – Life with Disease Synovial sarcoma metastatic – Diagnostics Congenital nephrogenic diabetes insipidus – Treatment Pulmonary fibrosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ripretinib Dinutuximab Beta ANERATRIGINE MESILATE Ponesimod Lisinopril Dihydrate Buprenorphine Mva-209-Fsp-B2 Pegargiminase Pacritinib TRIMIPRAMINE MALEATE Pantoprazole Dexpanthenol Mps-213 Treprostinil Sodium Crgd-Zw800-1 Art6043 SAROGLITAZAR HEMIMAGNESIUM Cloxacillin Sodium Quercetin Bi 706321 More therapies…

    Learn about Your Condition

    Chorioretinitis Coronary artery bypass Anogenital warts Acarodermatitis Glomerulonephritis membranous Pulmonary venous thrombosis Glanzmann's disease Aortic disorder Lymphoedema Tumour thrombosis Immunosuppression Pancreatic fistula Gastrointestinal disorder Foetal growth restriction Obsessive-compulsive disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Anti-neutrophil cytoplasmic antibody positive vasculitis

  • A Study of CND261 for Patients with Active ANCA-Positive Vasculitis That Has Not Responded to Previous Treatments

    Recruiting

    1 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Germany

  • A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

    Recruiting

    2 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    France Germany Italy Poland Spain

  • Study on the Effects of Rituximab and Cyclophosphamide in Patients with ANCA Vasculitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Cyclophosphamide
    • Rituximab
    The Netherlands

  • Comparison of Once Versus Twice Daily Prednisolone Administration on Blood Glucose Control in Patients with ANCA-Associated Vasculitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Prednisolone
    Austria

  • Study on Maintaining Remission in ANCA-Associated Vasculitis with Prednisone and Rituximab for Patients in Remission from Granulomatosis with Polyangiitis or Microscopic Polyangiitis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Prednisone
    • Rituximab
    France

  • Study on Pioglitazone for Improving Kidney Health in Patients with ANCA-Associated Vasculitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Dexchlorpheniramine
    • Methylprednisolone Hemisuccinate
    • Pioglitazone
    France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!